Skip to main content
Smart Investors Daily
LI

OTC · LIFD

LFTD Partners Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.10

Up+$0.00 (+0.00%)

Updated Aug 28, 2026, 12:02 PM

SID Score

2.3/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
4.15M
P/E ratio
69.12
Dividend yield
0.00%
52-week range
$0.07 – $0.42
Volume
4.71K
Avg. volume
2K

Price performance

LIFD price history

1M range · 5 trading sessions · Daily adjusted prices

LIFD closed at $0.10 after 5 trading sessions, down 48.21% for the selected period.

Last close
$0.10
Period change
-48.21%
Period low
$0.10
Period high
$0.20
Daily close
View OHLC price history
LIFD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Aug 24, 2026$0.17$0.17$0.071$0.1014.71K
Aug 20, 2026$0.195$0.195$0.195$0.1952.5K
Aug 19, 2026$0.1515$0.1515$0.1515$0.1515250
Aug 14, 2026$0.194$0.194$0.194$0.1941K
Aug 3, 2026$0.10$0.195$0.10$0.195350

Latest LIFD news

The latest Smart Investors Daily articles mentioning LIFD.

LIFD research

Overview

Company profile and research snapshot.

Company profile

LFTD PARTNERS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

globenewswire.com · Nov 17, 2025

LFTD Partners Inc. Reports Q3 2025 Basic EPS of $0.04

JACKSONVILLE, FL., Nov. 17, 2025 (GLOBE NEWSWIRE) -- LFTD Partners Inc. ("LFTD Partners" or the "Company") (OTCQB: LIFD), the corporate parent of leading hemp, wellness and energy products maker Lifted Made (“Lifted”), today reported its financial results for the third quarter ended September 30, 2025.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.